California Public Employees Retirement System Nurix Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$24.21 - $35.89 $547,146 - $811,114	-22,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$26.98 - $50.17 $55,983 - $104,102	-2,075 Reduced 8.41%	22,600 $703,000
Q4 2020 Feb 02, 2021	SELL	$22.85 - $48.44 $11,425 - $24,220	-500 Reduced 1.99%	24,675 $811,000
Q3 2020 Nov 05, 2020	BUY	$16.05 - $34.91 $404,058 - $878,859	25,175 New	25,175 $879,000

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

Black Rock Inc. New York, NY

6.82M
Shares

$135 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

4.28M
Shares

$84.9 Million
6.28% of portfolio
Vanguard Group Inc Valley Forge, PA

4.01M
Shares

$79.6 Million
0.0% of portfolio
Baker Bros. Advisors LP New York, NY

3.88M
Shares

$77 Million
0.93% of portfolio
Deep Track Capital, LP Greenwich, CT

3.87M
Shares

$76.7 Million
3.2% of portfolio

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account